Dapagliflozin And Saxagliptin Tablet, Film Coated
Product Images NDC 72205-438

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dapagliflozin And Saxagliptin (NDC 72205-438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapa-saxa-30s-count-container-label (Dapa Saxa 30s Count Container Label)

This is a description of a medication product labeled as Dapagliflozin and Saxagliptin Tablets with a strength of 10 mg of dapagliflozin and 5 mg of saxagliptin. The typical dosage is one tablet daily in the morning. The storage conditions are between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C and 30°C (59°F to 86°F). The medication is distributed by Novadoz Pharmaceuticals LLC, and it is indicated for prescription use only. It is important that the accompanying Medication Guide is dispensed to each patient.*

FDA Label Image

Dapa-saxa-90s-count-container-label (Dapa Saxa 90s Count Container Label)

Each tablet contains 10 mg dapagliflozin and 5 mg saxagliptin. The usual dosage is 1 tablet once daily in the morning. Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). The medication should not be used if the printed inner seal of the bottle is broken or missing. It is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals. Pharmacist should dispense the accompanying Medication Guide to each patient.*

FDA Label Image

Dapa-saxa-dapagliflozin-structure (Dapa Saxa Dapagliflozin Structure)

FDA Label Image

Fig-1 (Dapa Saxa Figure 1)

This is a summary of data related to a continuous glucose monitoring study. It includes information on the amount of glucose in the urine over a 24-hour period, as well as the dose of dapagliflozin (a diabetes medication) in milligrams. The data distinguishes between healthy subjects and those with type 2 diabetes (T2DM) using observed values and fitted lines.*

FDA Label Image

Dapa-saxa-saxagliptin-stucture. (Dapa Saxa Saxagliptin Stucture)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.